News Focus
News Focus
Followers 26
Posts 2781
Boards Moderated 0
Alias Born 03/18/2013

Re: yellow_bluff post# 89486

Friday, 08/19/2016 6:50:38 PM

Friday, August 19, 2016 6:50:38 PM

Post# of 447226
YB; I see your point about Medivation (MDVN) being similar to Amarin. Although a Cancer Drug company. A watershed event occurred on Nov. 2, 2011. MDVN stock went from 4.30 to 11 the following day. MDVN revs in 2013 were about $243M annual, Amarin is quickly approaching $130. MDVN has (3) drugs, AMRN has one drug with the potential of many more.

Amarin's watershed event is coming soon...... MDVN has 96% Institutional ownership with many deals pending, they are in a bidding war. I'm not concerned with Amarin's longevity in the market, I'm just concerned with my own ability to keep my hand off the sell button. Based upon MDVN success which I can see the same in store for Amarin. I want to retire and do something else with my life, it will be very hard to hold on for 5 more years is my guess for Amarin to get to $120.

Thanks for posting that analogy

Nuke
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News